Skip to main content

CELESTICA INC

For the period ended Mar 31, 2026. Filed Apr 27, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 27, 2026

CLS$222.92+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

Rule 10b5-1 Trading Plans

During the Company’s fiscal quarter ended March 31, 2026, the directors and officers listed below adopted, modified orterminated trading plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

On March 11, 2026, Robert Mionis, President and Chief Executive Officer, entered into a trading plan that provides for the sale of up to an aggregate of 556,394 common shares. The plan will terminate on March 4, 2027, subject to early termination for certain specified events set forth in the plan.

On March 13, 2026, Mandeep Chawla, Chief Financial Officer, entered into a trading plan that provides for the sale of up to an aggregate of 68,266 common shares. The plan will terminate on March 10, 2027, subject to early termination for certain specified events set forth in the plan.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.